NASDAQ : COAG

Hemab Therapeutics Holdings, Inc. Common Stock

$49.39 USD

$0.1 (0.2%)

Volume
567.77K
Average Volume
350.38K
Market Capitalization
$99.21M
P/E Ratio
-21.20
Dividend Yield
0.00%
Price Target
$50.00
Year High
$52.15
Year Low
$23.00
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$18.03

Annual earnings financials

COAG financial data with annual/quarterly toggle

COAG GAAP EPS - Annual & Quarterly

COAG Sales Revenue - Annual & Quarterly

COAG Shares Outstanding - Annual & Quarterly

Hover over bars to see exact values. Data includes up to 12 years of annual financials and up to 20 quarters of quarterly data from FMP Financial Data.

COAG Estimated and Actual Revenue by Quarter
COAG Estimated and Actual EPS by Quarter
COAG Analyst Forecasts — EBITDA & EBIT
Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 0 - - - - - -
2027-09-30 0 - - - - - -
2027-06-30 0 - - - - - -
2027-03-31 0 - - - - - -
2026-12-31 0 - - - - - -
2026-09-30 0 - - - - - -
COAG Analyst Forecasts — Net Income & SGA Expense
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 0 -31.36M -31.36M -31.36M - - -
2027-09-30 0 -26.24M -26.24M -26.24M - - -
2027-06-30 0 -28.5M -28.5M -28.5M - - -
2027-03-31 0 -23.84M -23.84M -23.84M - - -
2026-12-31 0 -26.07M -26.07M -26.07M - - -
2026-09-30 0 -23.86M -19.44M -21.65M - - -
COAG Analyst Forecasts — Revenue & EPS
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 0 - - - 1 -0.7097 -0.7097 -0.7097
2027-09-30 0 - - - 1 -0.5937 -0.5937 -0.5937
2027-06-30 0 - - - 1 -0.6449 -0.6449 -0.6449
2027-03-31 0 - - - 1 -0.53945 -0.53945 -0.53945
2026-12-31 0 - - - 1 -0.59 -0.59 -0.59
2026-09-30 0 - - - 2 -0.54 -0.44 -0.49